Prof. Mohamed Saad Zaghloul

Professor
Department of Radio-Therapy (NCI), National Cancer Institute, Cairo University, Egypt

Highest Degree
M.D. in Radiotherapy from Cairo University, Egypt

My URL
https://livedna.org/20.2612

Share this Profile

Area of Interest:

Biomedical Sciences
Cancer Research
Radiobiology
Pediatrics
Radiotherapy

Selected Publications

  1. Zaghloul, M.S., A. Nasr, M. Tolba, A. Refaat and A. Youssef et al., 2022. Hypofractionated radiation therapy for diffuse intrinsic pontine glioma: A noninferiority randomized study including 253 children. Int. J. Radiat. Oncol. Biol. Phys., 113: 360-368.
    CrossRef  |  Direct Link  |  

  2. Lazow, M.A., C. Fuller, M. DeWire, A. Lane and P. Bandopadhayay et al., 2022. Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG registry. Neuro-Oncology, 24: 821-833.
    CrossRef  |  Direct Link  |  

  3. Elhemaly, A., M.S. Zaghloul, S. Ahmed, H. Taha and A. Refaat et al., 2021. Prognostic factors and outcome of pineoblastoma: 10 years single-center experience. J. Egypt. Nat. Canc Inst., Vol. 33. 10.1186/s43046-021-00083-3.
    CrossRef  |  Direct Link  |  

  4. Bishr, M.K., M.S. Zaghloul, C. Elmaraghi, A. Galal and M.S. Abdelaziz et al., 2021. The radiotherapy utilization rate in pediatric tumors: An analysis of 13,305 patients. Radiother. Oncol., 154: 220-226.
    CrossRef  |  Direct Link  |  

  5. Amer, N., H. Taha, D. Hesham, N. Al-Shehaby and A. Mosaab et al., 2021. Aggresomes predict poor outcomes and implicate proteostasis in the pathogenesis of pediatric choroid plexus tumors. J. Neurooncol., 152: 67-78.
    CrossRef  |  Direct Link  |  

  6. van Heerden, J., M. Zaghloul, A. Neven, T. de Rojas and J. Geel et al., 2020. Pediatric oncology clinical trials and collaborative research in Africa: Current landscape and future perspectives. JCO Global Oncol., 6: 1264-1275.
    CrossRef  |  Direct Link  |  

  7. Santoni, M., D.Y.C. Heng, G. Aurilio, A. Iozzelli and L. Servi et al., 2020. Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in renal cell carcinoma. Curr. Drug Targets, 21: 416-423.
    CrossRef  |  Direct Link  |  

  8. Nakhla, S., A. Rahawy, M. Abd El Salam, T. Shalaby, M. Zaghloul and E. El-Abd, 2020. Radiosensitizing and phototherapeutic effects of AuNPs are mediated by differential noxa and bim gene expression in MCF-7 breast cancer cell line. IEEE Trans. Nanobiosci., 20: 20-27.
    CrossRef  |  Direct Link  |  

  9. Mosaab, A., M. El-Ayadi, E.N. Khorshed, N. Amer and A. Refaat et al., 2020. Histone H3K27M mutation overrides histological grading in pediatric gliomas. Sci. Rep., Vol. 10. 10.1038/s41598-020-65272-x.
    CrossRef  |  Direct Link  |  

  10. Elmaraghi, C., M.K. Bishr, A.G. Mousa, S. Ahmed and A. Refaat et al., 2020. Pediatric low grade focal brainstem glioma: Outcomes of different treatment strategies and prognostic factors. Future Oncol., 16: 2401-2410.
    CrossRef  |  Direct Link  |  

  11. Elghazawy, H., J. Bakkach, M.S. Zaghloul, A. Abusanad and M.M. Hussein et al., 2020. Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic. Future Oncol., 16: 2551-2567.
    CrossRef  |  Direct Link  |  

  12. Anacak, Y., E. Zubizarreta, M. Zaghloul, S. Laskar and J. Alert et al., 2020. The practice of paediatric radiation oncology in low- and middle-income countries: Outcomes of an international atomic energy agency study. Clin. Oncol., 33: E211-E220.
    CrossRef  |  Direct Link  |  

  13. Mousa, A.G., M.K. Bishr, L. Mula-Hussain and M.S. Zaghloul, 2019. Is economic status the main determinant of radiation therapy availability? The Arab world as an example of developing countries. Radiother. Oncol., 140: 182-189.
    CrossRef  |  Direct Link  |  

  14. Rosenblatt, E., R.R. Prasad, K. Hopkins, A. Polo and N. Ndlovu et al., 2018. Africa radiation oncology network (AFRONET): An IAEA telemedicine pilot project. J. Int. Soc. Telemed. Ehealth, Vol. 6. 10.29086/JISfTeH.6.e6.
    CrossRef  |  Direct Link  |  

  15. Bishr, M.K. and M.S. Zaghloul, 2018. Radiation therapy availability in Africa and Latin America: Two models of low and middle income countries. Int. J. Radiat. Oncol. Biol. Phys., 102: 490-498.
    CrossRef  |  Direct Link  |  

  16. Zaghloul, M.S. and T.M. Zaghloul, 2017. Adjuvant radiotherapy after radical cystectomy and ileal orthotopic neobladder. J. Egypt. Natl. Cancer Inst., 10.1016/j.jnci.2017.08.002.
    CrossRef  |  Direct Link  |  

  17. Baumann, B.C., P. Sargos, L.J. Eapen, J.A. Efstathiou and A. Choudhury et al., 2017. The rationale for post-operative radiation in localized bladder cancer. Bladder Cancer, 3: 19-30.
    CrossRef  |  Direct Link  |  

  18. Anacak, Y., M. Zaghloul and S. Laskar, 2017. Pediatric Radiation Oncology. In: Radiotherapy in Cancer Care: Facing the Global Challenges, Rosenblatt, E. and E. Zubizaretta (Eds.). International Atomic Energy Agency, Vienna, Austria, ISBN: 978-92-0-115013-4, pp: 325-338.

  19. Ahmed, G., M. Zamzam, M.S. Zaghloul, A. Kamel and R. Soliman et al., 2017. Outcome of resectable pediatric Ewing sarcoma of the ribs. J. Egypt. Natl. Cancer Inst., 29: 99-104.
    CrossRef  |  Direct Link  |  

  20. Zaghloul, M.S., M. Tolba, M.S. El Kady, M. Ezz Eldin, A. Amin, A.G. Mousa and M.S. Bakery, 2016. Simultaneous integrated boost-intensity modulated radiotherapy (SIB-IMRT) for the whole pelvis did not lead to significantly higher toxicity rates than prostate alone IMRT in prostate cancer patients. Clin. Oncol., Vol. 1. .
    Direct Link  |  

  21. Zaghloul, M.S., J.P. Christodouleas, A. Smith, A. Abdalla and H. William et al., 2016. Adjuvant sandwich chemotherapy and radiation versus adjuvant chemotherapy alone for locally advanced bladder cancer. Int. J. Radiat. Oncol. Biol. Phys., 96: S94-S94.
    CrossRef  |  Direct Link  |  

  22. Zaghloul, M.S., J.P. Christodouleas, A. Smith, A. Abdalla and H. William et al., 2016. A randomized clinical trial comparing adjuvant radiation versus chemo-RT versus chemotherapy alone after radical cystectomy for locally advanced bladder cancer. J. Clin. Oncol., 34: 356-356.
    CrossRef  |  Direct Link  |  

  23. Zaghloul, M.S., E. Eldebawy, S. Ahmed, H. Ammar and E. Khalil et al., 2016. Does primary tumor volume predict the outcome of pediatric nasopharyngeal carcinoma?: A prospective single-arm study using neoadjuvant chemotherapy and concomitant chemotherapy with intensity modulated radiotherapy. Asia-Pac. J. Clin. Oncol., 12: 143-150.
    CrossRef  |  PubMed  |  Direct Link  |  

  24. Zaghloul, M.S., 2016. The optimal dose of hypofractionated radiotherapy in diffuse intrinsic pontine glioma. Pediatr. Blood Cancer, 63: 948-948.
    CrossRef  |  PubMed  |  Direct Link  |  

  25. Zaghloul, M.S., 2016. Single pediatric neuro-oncology center may make difference in low/middle-income countries. Child's Nerv. Syst., 32: 241-242.
    CrossRef  |  PubMed  |  Direct Link  |  

  26. Zaghloul, M.S., 2016. Pediatric Neuro-Oncology in Low-/Middle-Income Countries. In: Neuro-Oncology-Newer Developments, Agrawal, A. (Ed.). InTech Publisher, Rijeka, Croatia, ISBN: 978-953-51-2426-9, pp: 447-475.

  27. Ezzat, S., M. Kamal, N. El-Khateeb, M. El-Beltagy and H. Taha et al., 2016. Pediatric brain tumors in a low/middle income country: Does it differ from that in developed world? J. Neuro-oncol., 126: 371-376.
    CrossRef  |  PubMed  |  Direct Link  |  

  28. El Beltagy, M.A., M. Reda, A. Enayet, M.S. Zaghloul and M. Awad et al., 2016. Treatment and outcome in 65 children with optic pathway gliomas. World Neurosurg., 89: 525-534.
    CrossRef  |  PubMed  |  Direct Link  |  

  29. Zekri, W., D. Yehia, M.M. Elshafie, M.S. Zaghloul and N. El-Kinaai et al., 2015. Bilateral clear cell sarcoma of the kidney. J. Egypt. National Cancer Inst., 27: 97-100.
    CrossRef  |  PubMed  |  Direct Link  |  

  30. Zaghloul, M.S., 2015. Has hypofractionated radiotherapy become the standard of care in pediatric DIPG? Child's Nerv. Syst., 31: 1221-1222.
    CrossRef  |  PubMed  |  Direct Link  |  

  31. Sidhom, I., E.E. Nadi, H. Taha, N. Elkinaai and M.S. Zaghloul et al., 2015. Clinical significance of anaplasia in childhood rhabdomyosarcoma. J. Egypt. National Cancer Inst., 27: 83-89.
    CrossRef  |  PubMed  |  Direct Link  |  

  32. Fawzy, M., M. El-Beltagy, M.E. Shafei, M.S. Zaghloul, N.A. Kinaai, A. Refaat and S. Azmy, 2015. Intraspinal neuroblastoma: Treatment options and neurological outcome of spinal cord compression. Oncol. Lett., 9: 907-911.
    CrossRef  |  PubMed  |  Direct Link  |  

  33. ElZomor, H., H. Taha, A. Aleieldin, R. Nour and M.S. Zaghloul et al., 2015. High risk retinoblastoma: Prevalence and success of treatment in developing countries. Ophthalmic Genet., 36: 287-289.
    CrossRef  |  PubMed  |  Direct Link  |  

  34. Zekri, W., A.S. Alfaar, D. Yehia, M.M. Elshafie and M.S. Zaghloul et al., 2014. Clear cell sarcoma of the kidney: Patients' characteristics and improved outcome in developing countries. Pediatr. Blood Cancer, 61: 2185-2190.
    CrossRef  |  Direct Link  |  

  35. Zaghloul, M.S., E. Eldebawy, S. Ahmed, A.G. Mousa and A. Amin et al., 2014. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): A randomized controlled trial. Radiother. Oncol., 111: 35-40.
    CrossRef  |  PubMed  |  Direct Link  |  

  36. Zaghloul, M.S., 2014. More effort is needed to improve the practice of radiotherapy in Africa. Clin. Oncol., 26: 730-731.
    CrossRef  |  PubMed  |  Direct Link  |  

  37. Zaghloul, M.S., 2013. Intensity modulated radiotherapy (IMRT) for pediatric cancer patients: The advantage and fear of second malignant neoplasm. J. Egypt. National Cancer Inst., 25: 1-3.
    CrossRef  |  PubMed  |  Direct Link  |  

  38. Rahman, H.A., M. Sedky, I. Mohsen, H. Taha and I. Loaye et al., 2013. Outcome of pediatric parameningeal rhabdomyosarcoma. The children cancer hospital, Egypt, experience. J. Egypt. National Cancer Inst., 25: 79-86.
    CrossRef  |  PubMed  |  Direct Link  |  

  39. Nadi, E.E., E.A. Moussa, W. Zekri, H. Taha and A. Yones et al., 2013. Outcome of rhabdomyosarcoma in first year of life: Children's cancer hospital 57357 Egypt. Sarcoma, Vol. 2013. 10.1155/2013/439213.
    CrossRef  |  PubMed  |  Direct Link  |  

  40. Moussa, E., M. Fawzy, A. Younis, M.E. Shafei and M.S. Zaghloul et al., 2013. Combined treatment strategy and outcome of high risk neuroblastoma: Experience of the children's cancer hospital-Egypt. J. Cancer Ther., 4: 1435-1442.
    CrossRef  |  Direct Link  |  

  41. Aly, A.M., E. Eldebawy, S. Ahmed, A. Refaat and E. Attala et al., 2013. Can conventional magnetic resonance imaging predict survival in pediatric diffuse intrinsic pontine glioma? A single institution experience. Egypt. J. Radiol. Nucl. Med., 44: 871-878.
    CrossRef  |  Direct Link  |  

  42. Zaghloul, M.S., E. Eldebawy, E. Attalah, S. Ahmed, M Nazmy and H.A. Anin, 2012. Supine craniospinal irradiation in children: patient position modification, dose uniformity and early adverse effects. Gulf. J. Oncol., 2012: 7-15.
    Direct Link  |  

  43. Zaghloul, M.S., 2012. Re-evaluation of the value of adjunctive modern radiotherapy in muscle-invasive bladder cancer. J. Solid Tumors, 2: 1-3.
    CrossRef  |  Direct Link  |  

  44. Zaghloul, M.S., 2012. Bladder cancer and schistosomiasis. J. Egypt. National Cancer Inst., 24: 151-159.
    CrossRef  |  Direct Link  |  

  45. Zaghloul, M.S. and I. Gouda, 2012. Schistosomiasis and bladder cancer: Similarities and differences from urothelial cancer. Expert Rev. Anticancer Ther., 12: 753-763.
    CrossRef  |  PubMed  |  Direct Link  |  

  46. Zaghloul, M.S. and I. Gouda, 2012. Bladder Cancer and Schistosomiasis: Is There a Difference for the Association? In: Bladder Cancer - From Basic Science to Robotic Surgery. Canda, A.E. (Ed.)., InTech, Rijeka, Croatia, pp 195-218.
    CrossRef  |  Direct Link  |  

  47. Wolpert, B.J., S. Amr, A.S. Doa`a, S. Ezzat, I. Gouda, I. Loay and M.S. Zaghloul et al 2012. Associations differ by sex for catechol-O-methyltransferase genotypes and bladder cancer risk in South Egypt. Urol. Oncol.: Semin. Original Invest., 30: 841-847.
    CrossRef  |  

  48. Eldesoky, I., E.M. Attalla, W.M. Elshemey and M.S. Zaghloul, 2012. A comparison of three commercial IMRT treatment planning systems for selected pediatric cases. J. Appl. Clin. Med. Phys., 13: 124-135.
    CrossRef  |  Direct Link  |  

  49. Zaghloul, M.S., 2011. Joint genitourinary cancer symposium between Egyptian and American centers. Expert Rev. Anticancer Ther., 11: 697-699.
    PubMed  |  

  50. Goerlitz, D., M. El-Daly, M. Abdel-Hamid, D.A. Saleh and M.S. Zaghloul et al., 2011. GSTM1, GSTT1 null variants and GPX1 single nucleotide polymorphism are not associated with bladder cancer risk in Egypt. Cancer Epidemiol. Biomarkers Prev., 20: 1552-1554.
    CrossRef  |  

  51. Eldebawy, E., E. Attalla, I. Eldesoky and M.S. Zaghloul, 2011. Geometrical uncertainty margins in 3D conformal radiotherapy in the pediatric age group. J. Egypt. Nat.Cancer Inst., 23: 55-60.
    CrossRef  |  Direct Link  |  

  52. El-Hafez, A.I., H.A. Shousha, M.S. Zaghloul and M.A. Abou Zeid, 2011. Influence of field size, depth, nominal dose rate and stem length on ion recombination correction factor in therapeutic photon beam. Am. J. Sci., 7: 206-213.
    Direct Link  |  

  53. Ahmed, S., M. Zaghloul and E. Eldebawy, 2011. 4118 POSTER Prospective Randomized Trial of Hypofractionated Conformal Radiotherapy for Pediatric Diffuse Pontine Glioma. Eur. J. Cancer, 47: S289-S289.
    CrossRef  |  

  54. Abou-elenein, H.S., E.M. Attalla, H. Ammar, I. Eldesoky, M. Farouk and M.S. Zaghloul, 2011. Megavoltage cone beam computed tomography: Commissioning and evaluation of patient dose. J. Med. Phys., 36: 205-212.
    Direct Link  |  

  55. Zaghloul, M.S., R. Boutrus, H. El-Hossieny, Y.A. Kader, I. El-Attar and M. Nazmy, 2010. A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer. Int. J. Clin. Oncol., 15: 382-389.
    PubMed  |  

  56. Zaghloul, M.S., A.G. Mousa, E. Eldebawy, E. Attalla, H. Shafik and S. Ezzat, 2010. Comparison of electronic portal imaging and cone beam computed tomography for position verification in children. Clin. Oncol. (R. Coll. Radiol.), 22: 850-861.
    PubMed  |  

  57. Zaghloul, M.S., 2010. The need to revisit adjuvant and neoadjuvant radiotherapy in bladder cancer. Expert Rev. Anticancer Ther., 10: 1527-1528.
    CrossRef  |  

  58. Zaghloul, M.S., 2010. Radiotherapy for Locally Advanced Bladder Cancer (Chapter 4). In: In: Bladder Cancer: Etymology, Diagnosis and Treatments, Nilsson, W.E. (Ed.)., Nova Publisher, London, ISBN: 978-1-61728-002-3, pp: 81-118.

  59. Zaghloul, M.S., 2010. Adjuvant and neoadjuvant radiotherapy for bladder cancer: Revisited. Future Oncol., 6: 1177-1191.
    Direct Link  |  

  60. Zaghloul, M.S. and A.G. Mousa, 2010. Trimodality treatment for bladder cancer: Does modern radiotherapy improve the end results?. Expert Rev. Anticancer Ther., 10: 1933-1944.
    PubMed  |  

  61. Wolpert, B.J., S. Amr, S. Ezzat, D. Saleh and I. Gouda et al., 2010. Estrogen exposure and bladder cancer risk in Egyptian women. Maturitas, 67: 353-357.
    PubMed  |  

  62. Zaghloul, M.S., 2009. The first children's cancer hospital, Egypt international scientific conference. Expert Rev. Anticancer Ther., 9: 1435-1437.
    PubMed  |  

  63. Zaghloul, M.S., A. Nouh, M. Moneer, M. El-Baradie, M. Nazmy and A. Younis, 2008. Time-trend in epidemiological and pathological features of schistosoma-associated bladder cancer. J. Egypt. Natl. Cancer Inst., 20: 168-174.
    PubMed  |  

  64. Zaghloul, M.S., 2008. Radiation oncology facilities in Africa: What is the most important equipment, staffing or guidelines?. Int. J. Radiat. Oncol. Biol. Phys., 71: 1600-1601.
    PubMed  |  

  65. Zaghloul, M.S., 2008. Does schistosoma-associated bladder cancer differ from urothelial cancer?. Proof from the laboratory and clinic. Cancer Genet. Cytogenet, 180: 160-162.
    PubMed  |  

  66. Khaled, H., M.E. Emara, R.M. Gaafar, O. Mansour, A.A. Warith, M.S. Zaghloul and O. El-Malt, 2008. Primary chemotherapy with low-dose prolonged infusion gemcitabine and cisplatin in patients with bladder cancer: A phase II trial. Urol. Oncol., 26: 133-136.
    PubMed  |  

  67. Felix, A.S., A.S. Soliman, H. Khaled, M.S. Zaghloul and M. Banerjee et al., 2008. The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control, 19: 421-429.
    PubMed  |  

  68. Zaghloul, M.S., S.A. El-Badawi and H.A. Elbaky, 2007. Professor Hassan K. Awwad; The Father of radiation oncology and radiobiology in Egypt and the Arab world, His good deeds last forever and inspire us for the future. J. Egypt. Natl. Cancer Inst., 19: 1-2.
    PubMed  |  

  69. Zaghloul, M.S., M. El-Baradie, Nouh, S. Abdel-Fatah, A. Taher and M. Shalaan, 2007. Prognostic index for primary adenocarcinoma of the urinary bladder. Gulf J. Oncol., 1: 47-54.
    PubMed  |  

  70. Zaghloul, M.S., 2007. Re: Patterns of initial transitional cell recurrence in patients after cystectomy. J. Urol., Vol. 178. .
    PubMed  |  

  71. Zaghloul, M.S. and S.A. El-Badawy, 2007. A Tribute to the father of radiation oncology and radiobiology in Egypt and the Arab world: Professor Hassan K. Awwad. Int. J. Radiat. Oncol. Biol. Phys., 69: 2-3.
    CrossRef  |  

  72. Murthy, V. and M.S. Zaghloul, 2007. Adjuvant radiotherapy in bladder cancer: Time to take a fresh look?. Urol. Oncol., 25: 353-354.
    CrossRef  |  

  73. Hashim, M., M. Sayed, F.F. Ibrahim, M.S. Zaghloul and S. El-Shazly, 2007. Molecular detection of uroplakin II in the peripheral blood of patients with urothelial carcinoma of the urinary bladder. Arab J. Lab. Med., 2: 267-280.

  74. Abdel-Hafez, A.I., M.B. Afifi, M.S. Zaghloul and M.A. Abou Zeid, 2007. Nominal Dose Rate and Stem Length Dependence of Polarity Correction Factor of PTW30006 Ionization Chamber Used in 6 and 10 MV Photon Beams. Egypt. J. Biophys., 13: 71-81.

  75. Zaghloul, M.S., H.M. Khaled, M. Lotayef and H. William, 2006. Adjuvant chemoradiotherapy after radical cystectomy in advanced high risk bladder cancer: A prospective randomized trial. ASCO Annu. Meeting Proc., Vol. 24. .
    Direct Link  |  

  76. Zaghloul, M.S., A. Nouh, M. Nazmy, S. Ramzy, A.S. Zaghloul, M.A. Sedira and E. Khalil, 2006. Long-term results of primary adenocarcinoma of the urinary bladder: A report on 192 patients. Urol. Oncol., 24: 13-20.
    PubMed  |  

  77. Zaghloul, M.S., 2006. Adjuvant radiation therapy for locally advanced bladder cancer. Touchbriefings, US Oncol. Dis., 2: 86-89.

  78. Ebeid, E.N., M. Zaghloul and M. Khairy, 2006. Clinical outcome of pediatric Hodgkin's disease in upper Egypt. ASCO Annu. Meeting Proc., Vol. 24. .
    Direct Link  |  

  79. Zaghloul, M.S., 2005. Adjuvant radiation therapy for muscle-invasive bladder cancer. Tunis. Med., 12: 92-93.
    PubMed  |  

  80. Khaled, H.K., N.G. El-Mawl, M.R. Hamza, M. El-Serafi and M.S. Zaghloul et al., 2005. Role of chemotherapy in advanced squamous cellcarcinoma of the bladder. Ann. Oncol., 5: 1-200.

  81. El-Sebaie, M., M.S. Zaghloul, G. Howard and A. Mokhtar, 2005. Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: A review of etiological features, natural history and management. Int. J. Clin. Oncol., 10: 20-25.
    PubMed  |  

  82. Cerciello, F., B. Hofstetter, S.A. Fatah, M. Zaghloul and B. Odermatt et al., 2005. G(2)/M cell cycle checkpoint is functional in cervical cancer patients after initiation of external beam radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 62: 1390-1398.
    CrossRef  |  

  83. Zaghloul, M.S., S.A. Aziz, A. Nouh, T.Z. Mohran, S. Shazely and A. Saber, 2003. Primary adenocarcinoma of the urinary bladder: Risk factors and value of postoperative radiotherapy. J. Egypt. Natl. Cancer Inst., 15: 193-200.
    Direct Link  |  

  84. Zaghloul, M.S, M.M. Elmongi, A.A. Hassan and B. Elgendi, 2003. Prognostic factors for bone-only metastasis in breast cancer patients. Proc. Am. Soc. Clin. Oncol., Vol. 22. .

  85. Saber, R.A., T.Z. Mahran, K.A. Enin, M.S. Zaghloul and S. Shehata, 2003. Response of skeletal metastases to systemic chemotherapy in patients with breast cancer. El-Minia Med, Bull., 14: 126-139.

  86. Ebeid, E.N., M.S. Zaghloul, A. Khairy, M. Zamzam, I. Sidhom and A. Saber, 2003. New therapeutic strategies in pediatric brain gliomas. Proc. Am. Soc. Clin. Oncol., Vol. 22. .

  87. Zaghloul, M.S., T.Z. Mohran, R.A. Saber and N. Agha, 2002. Post operative radiotherapy in bladder cancer. J. Egypt. Natl. Cancer Inst., 14: 161-168.
    Direct Link  |  

  88. Zaghloul, M.S., O.A. Khalil, H.S. Abdelghany and I.M. Ahmed, 2002. Role of helical computed tomography in staging of urinary bladder cancer. Egypt. J. Radiol. Nucl. Med., 33: 281-289.

  89. Khaled, H.M., M.S. Zaghloul, M. Ghoneim, R.A. Saber and M. Manie et al., 2002. A randomized phase III study of neoadjuvant chemotherapy for invasive bladder cancer with gemcitabine and cisplatin. Proc. Am. Soc. Clin. Oncol., Vol. 21. .

  90. Moneer, M., S. Isamail, H. Khaled, M. El-Gantery, M.S. Zaghloul and M. El-Didi, 2001. A new surgical strategy for breast conservation in locally advanced breast cancer that achieves a good locoregional control rate: Preliminary report. Breast, 10: 220-224.
    PubMed  |  

  91. Zaghloul, M.S., M. El-Naggar, A. El-Deeb, H. Khaled and N. Mokhtar, 2000. Prognostic implication of apoptesis and angiogenensis cervical uteri cancer. Int. J. Radiat. Oncol. Biol. Phys., 48: 1409-1415.
    PubMed  |  

  92. Khaled, H.M., M.R. Hamza, O. Mansour, R. Gaafer and M.S. Zaghloul, 2000. A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bieharzial bladder carcinoma. Eur. J. Cancer, 36: 34-37.
    PubMed  |  

  93. khorshid, A.M., N. Hamdy, D.S. Hindawy, M.S. Zaghloul and S. Farrag, 1997. Electomicroscopic study of radiation-induced apoptosis. J. Egypt. Natl. Cancer Inst., 9: 151-157.

  94. Zaghloul, M.S., M.H. Hussein, M. El-Naggar, I. El-Attar and G. Emira, 1997. Pathological versus clinical staging for children with Hodgkin's disease. Comparison of long-term results. J. Egypt. Natl. Cancer Inst., 9: 87-96.

  95. Zaghloul, M.S., 1996. Distant metastasis from bilharzial bladder cancer. Cancer, 77: 743-749.
    PubMed  |  

  96. Abou-Gabal, A., El-Badawy, M.S. Zaghloul, M. Bassiuony, O. El-Hattab and A. El-Arini, 1996. Localized ewing's sarcoma in children results of therapy. J. Egypt. Natl. Cancer Inst., 8: 9-15.

  97. Abou-Gabal, A., M.S. Zaghloul, M. El-Naggar and O. El-Hattab, 1996. Long term survivors in childhood rhabdomyosarcoma. Treatment strategy and prognostic factors. J. Egypt. Natl. Cancer Inst., 8: 23-27.

  98. Zaghloul, M.S., M.H. Hussein, A.A. Hassan, S.M. Ahmed, A.M.A. Wahab, I. El-Attar and A.A. Moneim, 1995. Prediction of abdominal involvement in children with Hodgkin disease. Med. J. Cairo Univ., 63: 267-273.

  99. Hussein, M.H., M.S. Zaghloul, A.A. Hassan, S.M. Ahmed, A.M.A. Wahab, I. El-Attar and H.A. Moneim, 1995. Long term results of paediatric Hodgkin's disease. Med. J. Cairo Univ., 63: 15-26.

  100. El-Kalawee, M., M.S. Zaghloul and H. Abdallah, 1995. Combind surgery and radiotherapy as a salvage therapy in the treatment of locoregional recurrence following mastectomy for breast cancer. Med. J. Cairo Univ., 63: 237-244.

  101. Abdallah, H., M. Barsoum, M. El-Serafi, A. El-Gayed and I. El-Attar et al., 1995. Long term results of adjuvant chemotherapy in carcinoma of the breast. NCI-Cairo experience. Med. J. Cairo Univ., 63: 115-119.

  102. Hussein, M.H., N.A. Wahby, M.S. Zaghloul, A.A. Wahab, M.R. Sakr and Abou-Gabal, 1994. Clinical evaluation of testicular biopsy in long term survivors of Acute lymphoblastic leukaemia. Egypt. J. Hematol., 19: 123-129.

  103. Zaghloul, M.S., N.M. Dahaba, A.A. Wahab, M.H. Hussein and M. El-Koutby, 1993. Nasopharyngeal carcinoma in childern and adolescents. Successful role of retrieval therapy. Tumori, 79: 123-127.
    PubMed  |  

  104. Zaghloul, M.S., M.J. Dorie and R.F. Kallman, 1993. 1nterleukin 1 modulatory effects on the action of chemotherapeutic drugs and localized irradiation of the lipduodenum and tumor. Int. J. Radiat Oncol. Biol. Phys., 26: 417-425.
    PubMed  |  

  105. Ezzat, S., H. Abdallah, M. El-Naggar, A. Zaki and M. Zaghloul, 1993. Preoperative versus postoperative irradiation in locally advanced carcinoma of the rectum. J. Egypt. Nat. Cancer Inst., 6: 55-62.

  106. Zaghloul, M.S., H.K. Awwad, H.H. Akoush, S. Omar, O. Soliman and I. El-Attar, 1992. Postoperative radiotherapy of carcinoma in Bilharzial bladder. Improved disease-free survival through improving local control. Int. J. Radiat. Oncol. Biol. Phys., 23: 511-517.
    PubMed  |  

  107. Zaghloul, M.S. and T.Y. Khatab, 1992. Dysgerminoma of the ovary. Good prognosis even in advanced stages. Int. J. Radiat. Oncol. Biol. Phys., 24: 161-165.
    PubMed  |  

  108. Awwad, H.K., Y. Khafagy, M. Barsoum, S. Ezzat and I. EI-Attar et al., 1992. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: Influence of tumour proliferation. Radiother. Oncol., 25: 261-266.
    PubMed  |  

  109. Kallman, R.F., D. Rapacchietta and M.S. Zaghloul, 1991. Schedule dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/Km mouse model systems. Int. J. Rad. Oncol. Biol. Phys., 20: 227-232.
    PubMed  |  

  110. Issa, S., Y. Youssef, B. Anaan, M. EI-Fouly, H. Massoud, M.S. Zaghloul and A. Saleh, 1991. Post-irradiation microbiological changes in DNA. content, antimicrobial sensitivity and some enzyme, activity in cancer bladder patients. J. Egypt. Natl. Cancer Inst., 5: 269-282.

  111. Hussein, M.H., N.A. Wahby, M.S. Zaghloul, A.A. Wahab and M.R. Sakr, 1991. Clinical evaluation of testicular biopsy in long-term survivors of Acute lymphoblastic leukaemia. J. Egypt. Med. Assoc., 74: 421-428.

  112. Wahab, A.A., M.S. Zaghloul, S. Issa and H. Hussein, 1990. Effect of therapy in neutrophil functions in children with acute lymphoblastic leukaemia. Egypt. J. Haematol., 15: 183-1505.

  113. Baky, H.A., M.S. Zaghloul, I. El-Ghoneimy, M. El-Baradie and M. El-Shahawy, 1990. Maxillary sinus tumours, 9 years experience. J. Egypt. Natl. Cancer Inst., 4: 771-779.

  114. Akoush, H., M.Y. Zayed, M.S. Zaghloul, M. El-Naggar and H.A. Moneim, 1990. Radiotherapy for nasopharyngeal carcinoma. Results of treatment. Egypt. Med. J., 7: 215-222.

  115. Zaghloul, M.S. and T.Y. Khattab, 1989. Dysgerminoma of the ovary. Results of different strategies of treatment and prognostic factors. Ain Shams Med. J., 8: 291-295.

  116. Wahab, A.A., M.S. Zaghloul, S.A. Radi, S. Issa, A. Moustafa and H. Hussein, 1989. Factors affecting the state of nutrition in children suffering from malignant tumours. J. Egypt. Natl. Cancer Inst., 4: 333-342.

  117. El-Gantiry, M., A. El-Weeshy, H.A. Baky, A. Hassan, M. Zaghloul, H. Akoush and S. El-Badawi, 1989. Results of treatment of, testicular seminoma. 7 years follow-up. Egypt. J. Radiol. Nucl. Med., 7: 167-174.

  118. Dorie, M.J., A.C. Allison, M.S. Zaghloul and R.F. Kallman, 1989. Interleukin 1 protects against the lethal effects of irradiation of mice but has no effect on tumors in the same animals. Proc. Soc. Exp. Biol. Med., 191: 23-29.
    PubMed  |  

  119. Baky, H.A., O. Abbasy, N.A. Salam, M.S. Zaghloul and H. Akoush, 1989. Radioprotective effect of WR 2721 on oral cavity structures in rats. A histopathological study. J. Egypt. Natl. Cancer Inst., 4: 173-182.

  120. Baky, H.A., M.S. Zaghloul, H. Akoush, A. El-Aaser, N.A. Salam, O. Abbasy and R. Ghali, 1989. Evaluation of radioprotective efficiency of the WR 2721 and Thiola on irradiated rat submandibular salivary gland. An enzymatic study. J. Egypt. Natl. Cancer Inst., 4: 235-246.

  121. Awwad, H.K., S. El-Badawi, H.A. Baky, M. Zaghloul, K. Osman, H. Akoush and K. Fairchild, 1989. Pharmacokinetics of etanidazole (SR-2508) in bladder and cervical cancer. Evidence of diffusion from urine. Int.J. Radiat. Oncol. Biol., Phys., 16: 1083-1084.
    PubMed  |  

  122. Eissa, S., M. Saad, M. Barsoum and S. Omar, 1988. Minimal Breast Cancer. In: In: Breast Cancer, Contesso, G. and S. Ornar (Eds.)., Kopra, London, pp: 154-157.

  123. Zaghloul, M.S., S. El-Badawi, S.A. Hadi, A.A. Wahab and R. Hamza et al., 1987. Five-year follow up after central nervous systern prophylaxis in children with Acute lymphoblastic leukaeniia. J. Egypt. Natl. Cancer Inst., 3: 63-70.

  124. Zaghloul, M.S., H.K. Awwad, O. Soliman, S. Omar and S. El-Badawi et al., 1986. Postoperative radiotherapy of carcinoma in Bilharzial bladder using a three-fractions per day regimen. Radiat. Oncol., 6: 257-265.

  125. Ezzat, S., H. Akoush, M.S. Zaghloul, M.A.A. El-Ella, H.A. Baky, H.A. Moneim and T. Helal, 1986. Results of treatment of solitary plasmacytoma. J. Egypt. Natl. Cancer Inst., 2: 515-521.

  126. El-Badawi, S.A., M.S. Barsoum, H. Akoush, H. Abdel-Baky, S. Ezzat, H.A. Moneim and M.S. Zaghloul, 1986. Sequential half body irradiation as systemic treatment of metastatic breast cancer. J. Egypt. Natl. Cancer Inst., 2: 495-500.

  127. Barsoum, M., M. El-Serafi, H. Akoush, M.A. Moneim, A. El-Khoudary, S. Ezzat and M. Zaghloul, 1986. Adjuvant therapy after radical mastectomy for T1 and T2 breast cancer. A randomized trial between chemotherapy alone and chemotherapy plus radiotherapy. J. Egypt. Natl. Cancer Inst., 3: 335-345.

  128. Akoush, H., M. Barsourn, H.A. Baky, S. Ezzat, H. Abdel-Moneim, M.S. Zaghloul and S. El-Badawi, 1986. Clinco-pathological features and results of treatment of malignant thymoma. J. Egypt. Natl. Cancer Inst., 2: 501-506.

  129. Akoush, H., H.A. Moneim and M.S. Zaghloul, 1986. Histocytosis-X: Presentation and management. J. Egypt. Natl. Cancer Inst., 2: 507-513.

  130. Ezzat, L., S. El-Badawi, R. Harnza, K. EI-Ghamrawy and M.S. Zaghloul et al., 1982. Prophylactic therapy for central nervous system in Acute lymphoblastic leukaemia. Med. J. Cairo. Univ., 50: 39-50.
Member since June, 2010